nomifensine has been researched along with Kidney Diseases in 1 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Habibi, B | 1 |
| Cartron, JP | 1 |
| Bretagne, M | 1 |
| Rouger, P | 1 |
| Salmon, C | 1 |
1 other study available for nomifensine and Kidney Diseases
| Article | Year |
|---|---|
Anti-nomifensine antibody causing immune hemolytic anemia and renal failure.
Topics: Agglutination Tests; Anemia, Hemolytic, Autoimmune; Antibodies; Antibody Formation; Binding, Competi | 1981 |